Anticoagulation
2
Pipeline Programs
5
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
PfizerNEW YORK, NY
2 programs1
ApixabanPhase 4
Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In ItalyN/A
Bristol Myers SquibbPRINCETON, NJ
1 programReal-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In ItalyN/A1 trial
Active Trials
CSL BehringIL - Bradley
1 programfour factor prothrombin complex concentratePHASE_41 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
CSL Behringfour factor prothrombin complex concentrate
Bristol Myers SquibbReal-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy
Clinical Trials (2)
Total enrollment: 9,964 patients across 2 trials
Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)
Start: Mar 2018Est. completion: Mar 202250 patients
Phase 4Unknown
NCT02921126Bristol Myers SquibbReal-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy
Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy
Start: Apr 2017Est. completion: Aug 20189,914 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.